Kidney health after age 60 requires a different framework than kidney health in younger adults — because the kidneys themselves change with age in ways that affect how kidney disease is identified, monitored, and managed, and because the conditions that most commonly damage kidneys (diabetes, hypertension, cardiovascular disease) reach their highest prevalence in older adults. Approximately 38% of adults over 65 have CKD by the KDIGO staging criteria, but a substantial portion of this represents age-related physiological decline rather than active kidney disease in the traditional sense — a distinction that has important implications for how an older adult and their care team interpret an eGFR below 60. This article describes what happens to kidney function with aging, how to distinguish age-related kidney changes from progressive kidney disease, and how to manage kidney health in adults over 60 in ways that reduce the risk of disease progression, cardiovascular complications, acute kidney injury, and medication toxicity. For adults building a systematic approach to monitoring kidney health at home, the article on home kidney health monitoring: what to track provides the complete framework. For a practical roadmap that integrates age-specific kidney management into daily life, see the companion article on living well with kidney disease: a practical roadmap.
How Kidney Function Changes With Age
Starting around age 30–40, kidney function declines gradually as a normal part of aging — independent of any disease. GFR declines at an average rate of approximately 0.75–1.0 mL/min/1.73m² per year after age 40, which means that by age 70, a person with no kidney disease may have an eGFR in the 60–75 range simply from the accumulation of age-related change. Several structural and functional changes contribute to this decline. Loss of nephron number: the kidneys have approximately one million nephrons at birth; by age 80, roughly 30–40% of those nephrons have been lost through normal attrition. Each remaining nephron compensates by filtering more blood (hyperfiltration), which sustains overall GFR at a near-normal level for decades but gradually becomes inadequate as more nephrons are lost. Reduced renal blood flow: renal blood flow decreases approximately 10% per decade after age 30–40, due to vascular changes including arterial stiffening, endothelial dysfunction, and atheromatous disease in the renal arteries. Reduced perfusion contributes to reduced GFR and also increases the kidney’s vulnerability to acute kidney injury from dehydration, NSAID use, or contrast agents. Reduced tubular function: the kidney tubules are responsible for reabsorbing electrolytes, concentrating urine, and excreting drugs and waste products. Tubular function declines with age even when GFR remains relatively preserved. Older adults have reduced ability to concentrate urine maximally in response to dehydration, reduced capacity to excrete excess potassium and acid loads, and slower clearance of renally-excreted medications — all with direct clinical implications. Reduced creatinine production: creatinine is a waste product of muscle metabolism, and older adults typically have less muscle mass than younger adults. Lower muscle mass means lower creatinine production, which means that in an older adult, a “normal” serum creatinine may actually represent significantly impaired kidney function — because the kidney is clearing a smaller creatinine load. This is one reason why eGFR is the preferred metric for monitoring kidney function in older adults rather than creatinine alone, and why the specific eGFR equations used (CKD-EPI) are designed to account for age. For a detailed explanation of how eGFR is calculated and what it means for older adults specifically, the article on what is eGFR covers the clinical framework. The NIDDK information on kidney disease in older adults, at the NIDDK CKD information page, provides accessible context for understanding age-related kidney changes in the broader CKD framework.
Distinguishing Age-Related Decline From Progressive Kidney Disease
One of the most clinically important questions in managing kidney health after 60 is whether a reduced eGFR in an older adult represents age-related physiological decline, actively progressive kidney disease, or both. The distinction matters because the management implications differ significantly: age-related decline that is stable does not require aggressive intervention, while progressive kidney disease does — regardless of the patient’s age. The role of proteinuria: the most important distinguishing marker between age-related kidney function decline and progressive kidney disease is proteinuria — specifically, the albumin-to-creatinine ratio (ACR). Age-related kidney function decline does not cause significant proteinuria. An older adult with an eGFR of 55 and an ACR below 30 mg/g likely has age-related decline without active glomerular disease. An older adult with an eGFR of 55 and an ACR above 300 mg/g almost certainly has active glomerular disease driving the function reduction — and that disease, if untreated, will progress. Proteinuria in an older adult should never be attributed to aging without evaluation of its cause. For a complete explanation of ACR and what different levels mean clinically, the article on albumin-to-creatinine ratio: what adults should know provides the framework. The rate of eGFR decline: stable CKD — whether age-related or disease-related — shows a slow decline within the expected physiological range of 0.75–1.0 mL/min/year. A decline faster than 3 mL/min/year in an older adult, or a sudden acceleration in the rate of decline, suggests active disease progression rather than aging alone. Tracking the eGFR trend rather than a single value allows this distinction to be made. Identifying the underlying cause: in older adults with eGFR below 60, identifying whether there is an underlying cause — uncontrolled hypertension, poorly managed diabetes, obstructive nephropathy from an enlarged prostate, atherosclerotic renovascular disease from renal artery stenosis — determines whether a treatable contributor exists. Age-related decline is not treatable; the underlying causes of kidney disease in older adults often are. The KDIGO CKD evaluation framework, available at the KDIGO CKD evaluation and management guidelines, provides the diagnostic approach that distinguishes age-related decline from disease-related CKD.
Medication Safety in Older Adults With Reduced Kidney Function
Medication safety is one of the most immediately actionable concerns in kidney health after 60. Older adults take an average of five or more prescription medications, and a substantial proportion of commonly used medications are renally cleared — meaning that declining kidney function reduces the rate at which these drugs are eliminated, leading to drug accumulation, elevated blood levels, and increased risk of toxicity. Several medication categories require particular attention in older adults with reduced kidney function. NSAIDs (ibuprofen, naproxen, aspirin at analgesic doses): NSAIDs inhibit prostaglandin synthesis, which is one mechanism by which the kidney maintains glomerular perfusion when blood pressure is low or blood volume is reduced. In older adults — who already have reduced renal reserve and often have some degree of dehydration — NSAID use can cause acute kidney injury that is sometimes severe. Older adults with eGFR below 60 should generally avoid NSAIDs and discuss alternatives with their care team. Contrast agents for imaging studies: contrast-induced nephropathy (acute kidney injury following administration of iodinated contrast for CT scans) is more likely in older adults with reduced kidney function. Before any contrast-enhanced imaging study, the ordering provider should be told the patient’s current creatinine and eGFR; for patients with significant CKD, the risk-benefit of contrast versus alternative imaging (ultrasound, non-contrast CT, MRI) should be specifically evaluated. ACE inhibitors and ARBs: these medications are kidney-protective in CKD with proteinuria, but they cause a predictable reduction in GFR when initiated or when the dose is increased, and they can cause dangerous hyperkalemia in patients with reduced kidney function — particularly in older adults with already-limited potassium excretion capacity. Potassium and creatinine monitoring within 1–2 weeks of starting or adjusting these medications is standard of care. Antibiotics: many antibiotics are renally cleared and require dose adjustment in patients with CKD. Fluoroquinolones (ciprofloxacin, levofloxacin), sulfonamides (trimethoprim-sulfamethoxazole), nitrofurantoin (which becomes ineffective and potentially toxic at low eGFR), and aminoglycosides are among the most commonly prescribed antibiotics that require adjustment or avoidance in CKD. Metformin: metformin is the first-line medication for type 2 diabetes and is safe and beneficial in CKD when the eGFR is above 30. At eGFR below 30 it should be discontinued due to the risk of lactic acidosis; at eGFR 30–45 it can be continued with dose reduction and monitoring; below 30 it is contraindicated. Many older adults with diabetes and reduced kidney function are not having their metformin status reviewed at each eGFR reassessment. The article on medication list template for kidney care covers the complete framework for documenting and reviewing medications at each nephrology appointment. The StatPearls reference on CKD medication management, at the StatPearls CKD management reference, provides the clinical framework for identifying drugs that require monitoring or adjustment.
Monitoring Priorities and Preventive Interventions After Age 60
For adults over 60, the monitoring and preventive interventions that most effectively protect kidney health address the primary causes of kidney disease in this age group — hypertension, diabetes, and the acute kidney injury events that accelerate chronic decline. Blood pressure control: hypertension is both a cause and a consequence of CKD, and blood pressure control is the most evidence-based intervention for slowing CKD progression in older adults. The target blood pressure in older adults with CKD is typically below 130/80 mmHg, though individualized targets that account for comorbid cardiovascular disease, frailty, and fall risk may be appropriate for specific patients. Home blood pressure monitoring is particularly important in older adults, whose office measurements are more often affected by white-coat hypertension and orthostatic hypotension than those of younger patients. Diabetes management: for older adults with diabetes and CKD, blood glucose control that avoids both hyperglycemia (which drives diabetic nephropathy progression) and hypoglycemia (which is more dangerous in older adults and in those with impaired awareness of hypoglycemia) is the clinical goal. SGLT2 inhibitors have demonstrated kidney-protective effects beyond glucose lowering in patients with diabetic nephropathy and are now guideline-recommended for most patients with type 2 diabetes and CKD. Hydration: older adults are at increased risk of dehydration due to reduced thirst sensation, reduced urinary concentrating ability, and medication effects (diuretics, laxatives). Dehydration in an older adult with reduced kidney function causes acute kidney injury more readily than in a younger adult with full kidney reserve. During hot weather, illness with vomiting or diarrhea, or any period of reduced fluid intake, older adults with CKD should specifically monitor fluid balance and contact their care team if urine output decreases significantly. Avoiding nephrotoxic exposures: beyond medications, environmental and occupational nephrotoxin exposure — heavy metals, certain herbal products, food contaminated with melamine, aristolochic acid in traditional herbal medicines — is disproportionately harmful in older adults with reduced kidney reserve. For patients taking any herbal or traditional medicine products, specific review of nephrotoxic risk is warranted. Annual monitoring schedule: adults over 60 with any risk factors for CKD (hypertension, diabetes, family history, prior AKI) should have annual creatinine, eGFR, and urine ACR checked even in the absence of known CKD. The NKF guidance on kidney health monitoring for older adults, at the NKF CKD resource page, provides accessible monitoring guidance that complements the clinical recommendations. For adults over 60 specifically concerned about preventive strategies, the companion article on preventive kidney care for older adults covers the full preventive framework in detail.
Sources: NIDDK CKD · KDIGO CKD Guidelines · National Kidney Foundation · StatPearls: CKD Management
Acute Kidney Injury in Older Adults: Prevention and Recognition
Acute kidney injury (AKI) — a sudden decline in kidney function over hours to days — is substantially more common in older adults than younger ones, is more likely to cause permanent kidney damage in the context of pre-existing reduced function, and is more likely to be precipitated by common exposures including dehydration, infections, and medications. Understanding the specific AKI risks that apply to older adults with reduced kidney reserve is a critical component of kidney health after 60. Why older adults are more vulnerable to AKI: the kidneys of older adults have reduced reserve capacity — fewer functional nephrons, lower renal blood flow, and reduced ability to autoregulate glomerular filtration in response to blood pressure changes. This means that any additional insult — a day of reduced fluid intake during a GI illness, a new NSAID for joint pain, a bout of dehydration during hot weather — can tip a kidneys that are functioning marginally into AKI. In younger adults with full kidney reserve, the same exposures cause no permanent harm. Common AKI precipitants in older adults: dehydration from illness (vomiting, diarrhea, fever, reduced oral intake) is the most common precipitant. NSAID use — particularly in combination with ACE inhibitors and diuretics — is among the most preventable causes of AKI in older adults (the “triple whammy” combination of NSAID plus ACE inhibitor/ARB plus diuretic is a well-recognized clinical risk pattern). Infections, particularly urinary tract infections and pneumonia, cause systemic inflammation that can trigger AKI through multiple mechanisms. Contrast for imaging studies can cause contrast-induced nephropathy, particularly in patients with reduced kidney function or who are dehydrated before the imaging. Cardiac events that reduce cardiac output and thereby reduce renal perfusion can cause AKI through hemodynamic mechanisms. Recognizing AKI early: the symptoms of AKI in older adults include decreased urine output (though some AKI is non-oliguric and urine output may be preserved), swelling in the legs and feet from fluid retention, increased shortness of breath, nausea, and fatigue. Importantly, AKI in older adults can be asymptomatic in its early stages — detectable only by lab values — which is one reason why monitoring creatinine and eGFR during and after any significant illness is important. What to do during a high-risk period: older adults with CKD or reduced kidney reserve should know in advance what to do when they are ill, dehydrated, or undergoing a procedure that poses AKI risk. Generally: avoid NSAIDs during illness; maintain fluid intake as best as possible; contact the care team if urine output decreases significantly; hold certain medications (ACE inhibitors, ARBs, diuretics, metformin) during acute illness on the care team’s instructions (patients should not hold these without discussing it with their provider first, as this is individually guided); and monitor creatinine after any significant illness or hospitalization. The NIDDK information on acute kidney injury, providing context for how AKI is related to CKD in older adults, is available through the NIDDK kidney disease page.
Kidney Health Goals That Are Specific to Older Adults
The goals of kidney health management in older adults differ in important ways from the goals in younger adults — not because the kidneys matter less, but because the clinical context is different. Older adults have more comorbidities, shorter life expectancy in some cases, and different risk-benefit trade-offs for interventions that would be straightforward in a 45-year-old. Understanding these age-specific considerations allows older adults and their care teams to set management goals that are appropriate for their individual situation. Individualized blood pressure targets: while the evidence-based target for blood pressure in CKD patients is generally below 130/80 mmHg, older adults — particularly those with orthostatic hypotension, fall risk, frailty, or advanced age (85+) — may benefit from individualized targets that are slightly higher, because the risk of hypotension and falls in this population may outweigh the incremental kidney protection of tighter control. The discussion of what blood pressure target is appropriate given the individual patient’s full clinical picture is worth having explicitly. Protein intake in older adults with CKD: protein restriction is sometimes recommended in CKD to reduce the protein load on the kidneys, but in older adults — who are already at significant risk of sarcopenia (muscle mass loss) and its associated outcomes including falls, hospitalization, and functional decline — aggressive protein restriction may cause harm. Most current guidelines recommend moderate protein restriction (0.6–0.8 g/kg/day) rather than very low protein diets in older adults with CKD, and renal dietitian involvement is particularly important in this population to balance the competing considerations. Transplantation in older adults: kidney transplantation can be appropriate in carefully selected older adults and can improve both survival and quality of life compared to dialysis. Age alone is not a contraindication to transplant evaluation; overall health status, cardiovascular risk, and life expectancy are more relevant. Older adults who may be transplant candidates should have this conversation with their nephrologist rather than assuming transplantation is not applicable to them. Dialysis decision-making: for older adults approaching kidney failure, the decision about whether to initiate dialysis is more complex than for younger adults. Conservative management (also called maximum conservative care — managing symptoms and complications of kidney failure without dialysis) is an appropriate choice for some older adults, particularly those with significant comorbidities and limited life expectancy, and this option should be discussed explicitly and early rather than presenting dialysis as the default. Quality of life as a primary goal: for older adults with CKD, maintaining quality of life — the ability to function independently, maintain important activities and relationships, and avoid the burden of intensive medical interventions that do not improve meaningful outcomes — is a legitimate and important goal alongside slowing CKD progression. Incorporating quality-of-life considerations explicitly into the management plan ensures that the clinical plan reflects what matters most to the individual patient. The StatPearls reference on CKD in older adults, available at the StatPearls CKD reference, covers the age-specific clinical considerations for CKD management. For a broader guide to daily living with kidney disease that applies specifically to older adults, the article on living well with kidney disease: a practical roadmap provides the practical framework.
Managing kidney health after age 60 means working within a more complex clinical picture than at younger ages — more medications, more comorbidities, more potential for drug interactions, and less physiological reserve to absorb acute insults. But the core principles remain straightforward: know your numbers, protect against avoidable nephrotoxic exposures, keep blood pressure controlled, manage diabetes if present, and monitor consistently so that any deterioration is detected when there is still time to respond. Older adults who take an active role in their kidney health — tracking labs, understanding their medications, communicating clearly with their care team, and building the structures that support consistent monitoring — achieve better outcomes than those who are passive recipients of management decisions they don’t fully understand. The resources needed to build that active management approach are available: the monitoring framework in home kidney health monitoring: what to track, the medication management framework in the medication list template for kidney care, and the appointment preparation structure in the doctor visit checklist for kidney health together provide the complete toolkit for managing kidney health effectively after 60.
The section explaining why a normal-looking creatinine can hide significant kidney function loss in older adults was the most useful thing I’ve read about my situation. At 72, my creatinine has been 1.1 for years and my primary care doctor always said it was fine. When I finally had an eGFR calculated, it was 52. The creatinine was ‘normal’ because I’ve lost muscle mass as I’ve gotten older, and the kidney was clearing a smaller creatinine load rather than functioning normally. I had CKD stage 3a without knowing it because nobody was looking beyond the creatinine number. My nephrologist said this is extremely common in older women especially.
Eleanor, the creatinine-normal-but-eGFR-reduced pattern in older women is both very common and very consequential — because a ‘normal’ creatinine in a petite older woman can correspond to an eGFR in the 40s or even lower, and that eGFR level changes medication dosing requirements, affects which contrast imaging studies can be done safely, and determines whether nephrology referral is appropriate. The reason the creatinine-only approach is so unreliable in this population is exactly what you described: muscle mass is the substrate for creatinine production, and lower muscle mass means lower creatinine production even with the same degree of kidney function decline. eGFR is the right metric — it accounts for this — but only if it is calculated and reported, which requires someone to order it.
The warning about NSAIDs is one I wish had reached me earlier. I was taking ibuprofen regularly for joint pain — at least 400mg twice a day for several months — while also on an ACE inhibitor and a diuretic for blood pressure. I ended up with an acute kidney injury that took my eGFR from 58 down to 31 over about three weeks. It partially recovered but never returned to baseline. My nephrologist called the combination I was taking — NSAID plus ACE inhibitor plus diuretic — a ‘triple whammy’ and said it’s a well-known cause of AKI in older adults. Knowing that NSAIDs are specifically dangerous in this combination would have changed what I did with that joint pain.